TRAITEMENT D'ETATS PATHOLOGIQUES ASSOCIES A LA BIODISPONIBILITE REDUITE DE L'OXYDE NITRIQUE, Y COMPRIS DES ETATS PATHOLOGIQUES CAUSES PAR L'ACTIVITE ELEVEE DE L'ARGINASE
The invention features methods and compositions for treatment of conditionsassociated with decreased nitric oxide bioavailability, such as a conditionassociated with elevated arginase activity, using an arginine-based therapy,including combination therapy with an arginase inhibitor and/or magnesium.